These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35305377)

  • 1. Evolution of antibodies against SARS-CoV-2 over seven months: Experience of the nationwide seroprevalence ENE-COVID study in Spain.
    Pérez-Olmeda M; Saugar JM; Fernández-García A; Pérez-Gómez B; Pollán M; Avellón A; Pastor-Barriuso R; Fernández-de Larrea N; Martín M; Cruz I; Sanmartín JL; Fedele G; Paniagua JL; Muñoz-Montalvo JF; Blanco F; Yotti R; Oteo-Iglesias J;
    J Clin Virol; 2022 Apr; 149():105130. PubMed ID: 35305377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.
    Pollán M; Pérez-Gómez B; Pastor-Barriuso R; Oteo J; Hernán MA; Pérez-Olmeda M; Sanmartín JL; Fernández-García A; Cruz I; Fernández de Larrea N; Molina M; Rodríguez-Cabrera F; Martín M; Merino-Amador P; León Paniagua J; Muñoz-Montalvo JF; Blanco F; Yotti R;
    Lancet; 2020 Aug; 396(10250):535-544. PubMed ID: 32645347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June-July 2021: A population-based cross-sectional study.
    Murhekar MV; Bhatnagar T; Thangaraj JWV; Saravanakumar V; Santhosh Kumar M; Selvaraju S; Rade K; Kumar CPG; Sabarinathan R; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chakraborty D; Chopra V; Das D; Devi KR; Dwivedi GR; Jain A; Khan SMS; Kumar MS; Laxmaiah A; Madhukar M; Mahapatra A; Ramesh T; Rangaraju C; Turuk J; Yadav S; Bhargava B;
    PLoS Med; 2021 Dec; 18(12):e1003877. PubMed ID: 34890407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trend in seroprevalence of SARS-CoV-2 (IgG antibody) among tribal-dominated population: Findings from Jharkhand, India.
    Mahapatra A; Palo SK; Bhattacharya D; Kanungo S; Kshatri JS; Mishra BK; Mansingh A; Parai D; Pattnaik M; Choudhary HR; Dash GC; Mohanta AR; Bishoyee A; Mohanty P; Mandal N; Dayal R; Mitra A; Pati S
    Indian J Med Res; 2022 Aug; 156(2):228-239. PubMed ID: 36629182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating immunity to SARS-CoV-2 in nursing home residents using saliva IgG.
    Katz MJ; Heaney CD; Pisanic N; Smith L; Bigelow BF; Sheikh F; Boudreau A; Kruczynski K; Hsu YJ; Salinas AB; Cosgrove SE; Rock C
    J Am Geriatr Soc; 2022 Mar; 70(3):659-668. PubMed ID: 35038344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Two Chemiluminescent and Three ELISA Immunoassays for the Detection of SARS-CoV-2 IgG Antibodies: Implications for Disease Diagnosis and Patients' Management.
    Speletas M; Kyritsi MA; Vontas A; Theodoridou A; Chrysanthidis T; Hatzianastasiou S; Petinaki E; Hadjichristodoulou C
    Front Immunol; 2020; 11():609242. PubMed ID: 33424863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays.
    Allen N; Brady M; Carrion Martin AI; Domegan L; Walsh C; Houlihan E; Kerr C; Doherty L; King J; Doheny M; Griffin D; Molloy M; Dunne J; Crowley V; Holmes P; Keogh E; Naughton S; Kelly M; O'Rourke F; Lynagh Y; Crowley B; de Gascun C; Holder P; Bergin C; Fleming C; Ni Riain U; Conlon N;
    Microbiol Spectr; 2021 Oct; 9(2):e0039121. PubMed ID: 34585976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Serological Snapshot of COVID-19 Initial Stages in Israel by a 6-Plex Antigen Array.
    Fisher M; Levy H; Fatelevich E; Afrimov Y; Ben-Shmuel A; Rosenfeld R; Noy-Porat T; Glinert I; Sittner A; Biber A; Belkin A; Bar-David E; Puni R; Levy I; Mazor O; Weiss S; Mechaly A
    Microbiol Spectr; 2021 Oct; 9(2):e0087021. PubMed ID: 34612689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of IgG and Subclasses against the Nucleocapsid of SARS-CoV-2 in Health Workers.
    Cortés-Sarabia K; Palomares-Monterrubio KH; Velázquez-Moreno JO; Luna-Pineda VM; Leyva-Vázquez MA; Vences-Velázquez A; Dircio-Maldonado R; Del Moral-Hernández O; Illades-Aguiar B
    Viruses; 2023 Apr; 15(4):. PubMed ID: 37112935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence and dynamics of anti-SARS-CoV-2 antibodies: a longitudinal study based on patients with underlying diseases in Wuhan.
    Yang J; Ma L; Guo L; Zhang T; Leng Z; Jia M; Chen F; Qi W; Zhang X; Wang Q; Yang Y; Feng L; Ren L; Yang W; Wang C
    Respir Res; 2022 Jul; 23(1):188. PubMed ID: 35841095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of antibodies against SARS-CoV-2 in the Norwegian population, August 2021.
    Tunheim G; Rø GØI; Chopra A; Aase A; Kran AB; Vaage JT; Lund-Johansen F; Hungnes O
    Influenza Other Respir Viruses; 2022 Nov; 16(6):1004-1013. PubMed ID: 35770841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence and longevity of SARS-CoV-2 nucleocapsid antigen-IgG among health care workers in a large COVID-19 public hospital in Saudi Arabia: A prospective cohort study.
    Alasmari F; Mukahal M; Alqurashi AA; Huq M; Alabdrabalnabi F; AlJurayyan A; Alkahtani SM; Assari FS; Bashaweeh R; Salam R; Aldera S; Alkinani OM; Almutairi T; AlEnizi K; Tleyjeh I
    PLoS One; 2022; 17(8):e0272818. PubMed ID: 35960736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study.
    He Z; Ren L; Yang J; Guo L; Feng L; Ma C; Wang X; Leng Z; Tong X; Zhou W; Wang G; Zhang T; Guo Y; Wu C; Wang Q; Liu M; Wang C; Jia M; Hu X; Wang Y; Zhang X; Hu R; Zhong J; Yang J; Dai J; Chen L; Zhou X; Wang J; Yang W; Wang C
    Lancet; 2021 Mar; 397(10279):1075-1084. PubMed ID: 33743869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence, correlates and kinetics of SARS-CoV-2 nucleocapsid IgG antibody in healthcare workers and nonclinical staff at a tertiary hospital: A prevaccine census study.
    Maina D; Omuse G; Ong'ete G; Mugaine P; Sayed S; Moloo Z; Shah R; Etyang A; Adam R
    PLoS One; 2022; 17(10):e0267619. PubMed ID: 36301926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Seroprevalence Study in Pediatric Patients and Health Care Workers Using Multiplex Antibody Immunoassays.
    Prados de la Torre E; Obando I; Vidal M; de Felipe B; Aguilar R; Izquierdo L; Carolis C; Olbrich P; Capilla-Miranda A; Serra P; Santamaria P; Blanco-Lobo P; Moncunill G; Rodríguez-Ortega MJ; Dobaño C
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of humoral immune response over 17 months of COVID-19 pandemic in a large cohort of healthcare workers in Spain: the ProHEpiC-19 study.
    Violán C; Torán-Monserrat P; Quirant B; Lamonja-Vicente N; Carrasco-Ribelles LA; Chacón C; Manresa-Dominguez JM; Ramos-Roure F; Dacosta-Aguayo R; Palacios-Fernández C; Roso-Llorach A; Pujol A; Ouchi D; Monteagudo M; Montero-Alia P; Garcia-Sierra R; Arméstar F; Doladé M; Prat N; Bonet JM; Clotet B; Blanco I; Boigues-Pons M; Moreno-Millán N; Prado JG; Cáceres EMM;
    BMC Infect Dis; 2022 Sep; 22(1):721. PubMed ID: 36057544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of SARS-CoV-2 Assessed by Four Chemiluminescence Immunoassays and One Immunocromatography Test for SARS-Cov-2.
    Cerino P; Gallo A; Pierri B; Buonerba C; Di Concilio D; Cuomo MC; Vassallo L; Lo Conte G; Coppola A; Pizzolante A; Boccia G; Ferrucci V; Atripaldi L; Triassi M; Pacella D; Cennamo M; Romano P; Sorbo TM; Furno A; Catapano O; Contina A; Perruolo G; D'Amora M; Terracciano D; Portella G
    Front Public Health; 2021; 9():649781. PubMed ID: 33996728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Natural SARS-CoV-2 Infection in Seroprevalence Studies Among Vaccinated Populations.
    Demmer RT; Baumgartner B; Wiggen TD; Ulrich AK; Strickland AJ; Naumchik BM; Bohn B; Walsh S; Smith S; Kline S; Stovitz SD; Yendell S; Beebe TJ; Hedberg C
    Mayo Clin Proc; 2022 Apr; 97(4):754-760. PubMed ID: 35379422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Qualitative Comparison of the Abbott SARS-CoV-2 IgG II Quant Assay against Commonly Used Canadian SARS-CoV-2 Enzyme Immunoassays in Blood Donor Retention Specimens, April 2020 to March 2021.
    Abe KT; Rathod B; Colwill K; Gingras AC; Tuite A; Robbins NF; Orjuela G; Jenkins C; Conrod V; Yi QL; O'Brien SF; Drews SJ
    Microbiol Spectr; 2022 Jun; 10(3):e0113422. PubMed ID: 35652636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.